InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

EXELIXIS, INC.

EXEL Clue Score84
United States Fiscal year ends January CIK 0000939767 Results filed 29 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

6
Insider
Date
Role
Action
Shares
Price
Amount
Mary C Beckerle
10 Aug 2026
Director
Sold on a plan
9,812
$53.66
$526.51K
Sue Gail Eckhardt
1 Jun 2026
Director
Sold on a plan
9,812
$50.14
$491.97K
Jack L Wyszomierski
1 Jun 2026
Director
Sold on a plan
3,925
$50.55
$198.41K
Brenda Hefti
18 May 2026
SVP and General Counsel
Sold on a plan
6,625
$50.21
$332.64K
Brenda Hefti
18 Feb 2026
SVP and General Counsel
Sold on a plan
18,669
$44.01
$821.62K
Sue Gail Eckhardt
13 Feb 2026
Director
Sold on a plan
3,856
$43.79
$168.85K
Show all 34 transactions →

What was left out

Form 4 filings counted 53
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 10
Sales at will 16
Transactions with no price 0
Shares from compensation/vesting 4,810,436
History held since 6 Oct 2006